Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,100,276
-$220,095 QoQ
Shares Held
16,624
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#816
of 2,266 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nilsine Partners, LLC holds $35,772,221 across 11 Drug Manufacturers - General names. GILD ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,082 | $13,292,084 | |
| 2 | JNJ |
Johnson & Johnson
|
23,855 | $6,058,454 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,144 | $3,359,504 | |
| 4 | NVO |
Novo Nordisk A S
|
69,503 | $3,331,973 | |
| 5 | AMGN |
Amgen Inc
|
9,193 | $3,328,969 | |
| 6 | ABBV |
AbbVie Inc.
|
10,103 | $2,542,318 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
16,624 | $2,100,276 | |
| 8 | NVS |
Novartis AG
|
4,809 | $753,666 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,100,276 | 16,624 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,320,371 | 16,649 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,901,365 | 15,491 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,562,769 | 14,079 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,398,403 | 12,613 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $207,964 | 1,856 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $968,072 | 13,216 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,006,630 | 12,426 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $891,336 | 11,894 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $906,882 | 11,767 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $973,818 | 11,737 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||